• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NPM-ALK是ALK阳性间变性大细胞淋巴瘤中癌蛋白FOXM1的关键调节因子。

NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma.

作者信息

Haque Moinul, Li Jing, Huang Yung-Hsing, Almowaled Meaad, Barger Carter J, Karpf Adam R, Wang Peng, Chen Will, Turner Suzanne D, Lai Raymond

机构信息

Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G2R3, Canada.

Electron Microscopy Center, Basic Medical Science College, Harbin Medical University, Harbin 150080, Heilongjiang, China.

出版信息

Cancers (Basel). 2019 Aug 6;11(8):1119. doi: 10.3390/cancers11081119.

DOI:10.3390/cancers11081119
PMID:31390744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6721812/
Abstract

Forkhead Box M1 (FOXM1) is an oncogenic transcription factor implicated in the pathogenesis of solid and hematologic cancers. In this study, we examined the significance of FOXM1 in NPM-ALK-positive anaplastic large cell lymphoma (NPM-ALK + ALCL), with a focus on how it interacts with NPM-ALK, which is a key oncogenic driver in these tumors. FOXM1 was expressed in NPM-ALK + ALCL cell lines (5/5), patient samples (21/21), and tumors arising in NPM-ALK transgenic mice (4/4). FOXM1 was localized in the nuclei and confirmed to be transcriptionally active. Inhibition of FOXM1 in two NPM-ALK + ALCL cells using shRNA and pharmalogic agent (thiostrepton) resulted in reductions in cell growth and soft-agar colony formation, which were associated with apoptosis and cell-cycle arrest. FOXM1 is functionally linked to NPM-ALK, as FOXM1 enhanced phosphorylation of the NPM-ALK/STAT3 axis. Conversely, DNA binding and transcriptional activity of FOXM1 was dependent on the expression of NPM-ALK. Further studies showed that this dependency hinges on the binding of FOXM1 to NPM1 that heterodimerizes with NPM-ALK, and the phosphorylation status of NPM-ALK. In conclusion, we identified FOXM1 as an important oncogenic protein in NPM-ALK+ ALCL. Our results exemplified that NPM-ALK exerts oncogenic effects in the nuclei and illustrated a novel role of NPM1 in NPM-ALK pathobiology.

摘要

叉头框M1(FOXM1)是一种致癌转录因子,与实体癌和血液系统癌症的发病机制有关。在本研究中,我们研究了FOXM1在NPM-ALK阳性间变性大细胞淋巴瘤(NPM-ALK + ALCL)中的意义,重点关注其与NPM-ALK的相互作用方式,NPM-ALK是这些肿瘤中的关键致癌驱动因子。FOXM1在NPM-ALK + ALCL细胞系(5/5)、患者样本(21/21)以及NPM-ALK转基因小鼠产生的肿瘤(4/4)中均有表达。FOXM1定位于细胞核,并被证实具有转录活性。使用短发夹RNA(shRNA)和药物(硫链丝菌素)抑制两种NPM-ALK + ALCL细胞中的FOXM1,导致细胞生长和软琼脂集落形成减少,这与细胞凋亡和细胞周期停滞有关。FOXM1在功能上与NPM-ALK相关联,因为FOXM1增强了NPM-ALK/STAT3轴的磷酸化。相反,FOXM1的DNA结合和转录活性依赖于NPM-ALK的表达。进一步的研究表明,这种依赖性取决于FOXM1与与NPM-ALK异二聚化的NPM1的结合以及NPM-ALK的磷酸化状态。总之,我们确定FOXM1是NPM-ALK + ALCL中一种重要的致癌蛋白。我们的结果表明NPM-ALK在细胞核中发挥致癌作用,并阐明了NPM1在NPM-ALK病理生物学中的新作用。

相似文献

1
NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma.NPM-ALK是ALK阳性间变性大细胞淋巴瘤中癌蛋白FOXM1的关键调节因子。
Cancers (Basel). 2019 Aug 6;11(8):1119. doi: 10.3390/cancers11081119.
2
The heat shock protein-90 co-chaperone, Cyclophilin 40, promotes ALK-positive, anaplastic large cell lymphoma viability and its expression is regulated by the NPM-ALK oncoprotein.热休克蛋白 90 共伴侣蛋白,亲环素 40,促进间变性大细胞淋巴瘤 ALK 阳性细胞的存活,其表达受 NPM-ALK 癌蛋白的调控。
BMC Cancer. 2012 Jun 8;12:229. doi: 10.1186/1471-2407-12-229.
3
STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.STAT1 被致癌酪氨酸激酶 NPM-ALK 在 ALK 阳性间变大细胞淋巴瘤中磷酸化和下调。
Blood. 2015 Jul 16;126(3):336-45. doi: 10.1182/blood-2014-10-603738. Epub 2015 Apr 28.
4
Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.PF-2341066(一种间变性淋巴瘤激酶和c-Met的新型抑制剂)在间变性大细胞淋巴瘤实验模型中的减瘤抗肿瘤活性。
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3314-22. doi: 10.1158/1535-7163.MCT-07-0365.
5
Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma.水飞蓟宾可抑制核仁磷酸蛋白-间变性淋巴瘤激酶(NPM-ALK),有效诱导细胞凋亡,并增强ALK阳性间变性大细胞淋巴瘤的化疗敏感性。
Leuk Lymphoma. 2016 May;57(5):1154-62. doi: 10.3109/10428194.2015.1068306. Epub 2015 Jul 1.
6
Methotrexate significantly induces apoptosis by inhibiting STAT3 activation in NPM-ALK-positive ALCL cells.甲氨蝶呤通过抑制 NPM-ALK 阳性 ALCL 细胞中 STAT3 的激活显著诱导细胞凋亡。
Biochem Pharmacol. 2019 Dec;170:113666. doi: 10.1016/j.bcp.2019.113666. Epub 2019 Oct 22.
7
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.NPM-ALK致癌激酶通过激活间变性大细胞淋巴瘤中的JNK/cJun信号通路促进细胞周期进程。
Blood. 2007 Sep 1;110(5):1621-30. doi: 10.1182/blood-2006-11-059451. Epub 2007 Apr 6.
8
The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma.胚胎干细胞标志物 SALL4 在间变性大细胞淋巴瘤中 ALK 阳性表达及其致癌作用。
Cell Signal. 2012 Oct;24(10):1955-63. doi: 10.1016/j.cellsig.2012.06.005. Epub 2012 Jun 26.
9
EBP2, a novel NPM-ALK-interacting protein in the nucleolus, contributes to the proliferation of ALCL cells by regulating tumor suppressor p53.EBP2,核仁中一种新型的 NPM-ALK 相互作用蛋白,通过调节肿瘤抑制因子 p53 促进 ALCL 细胞的增殖。
Mol Oncol. 2021 Jan;15(1):167-194. doi: 10.1002/1878-0261.12822. Epub 2020 Nov 19.
10
Crizotinib (PF-2341066) induces apoptosis due to downregulation of pSTAT3 and BCL-2 family proteins in NPM-ALK(+) anaplastic large cell lymphoma.克唑替尼(PF-2341066)通过下调 NPM-ALK(+)间变大细胞淋巴瘤中的 pSTAT3 和 BCL-2 家族蛋白诱导细胞凋亡。
Leuk Res. 2014 Apr;38(4):503-8. doi: 10.1016/j.leukres.2013.12.027. Epub 2014 Jan 8.

引用本文的文献

1
Nuclear NPM-ALK Protects Myc from Proteasomal Degradation and Contributes to Its High Expression in Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma.核 NPM-ALK 保护 Myc 免于蛋白酶体降解,并有助于 ALK 阳性间变大细胞淋巴瘤中的癌症干细胞样细胞中高表达。
Int J Mol Sci. 2023 Sep 20;24(18):14337. doi: 10.3390/ijms241814337.
2
Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis.蕈样肉芽肿早期和肿瘤期的基因表达谱分析——应用激光捕获/单细胞微切割和 NanoString 分析的概念验证研究。
Cells. 2021 Nov 16;10(11):3190. doi: 10.3390/cells10113190.
3

本文引用的文献

1
Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.泛癌分析揭示癌症中FOXM1过表达的基因组特征。
Cancers (Basel). 2019 Feb 21;11(2):251. doi: 10.3390/cancers11020251.
2
FOXM1 contributes to treatment failure in acute myeloid leukemia.FOXM1 促进急性髓系白血病的治疗失败。
JCI Insight. 2018 Aug 9;3(15). doi: 10.1172/jci.insight.121583.
3
EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients.EML4-ALK 变体:生物学和分子特性及其对患者的影响
NRF1-regulated CircNSUN2 promotes lymphoma progression through activating Wnt signaling pathway via stabilizing HMGA1.
NRF1 调控的 circNSUN2 通过稳定 HMGA1 激活 Wnt 信号通路促进淋巴瘤进展。
Cell Cycle. 2021 May;20(9):819-828. doi: 10.1080/15384101.2021.1897272. Epub 2021 Apr 16.
4
Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia.血液系统恶性肿瘤中的核磷蛋白1(NPM1)异常以及急性髓系白血病中突变型NPM1的治疗靶点
Ther Adv Hematol. 2020 Feb 3;11:2040620719899818. doi: 10.1177/2040620719899818. eCollection 2020.
Cancers (Basel). 2017 Sep 5;9(9):118. doi: 10.3390/cancers9090118.
4
Biological and clinical consequences of NPM1 mutations in AML.NPM1 突变在 AML 中的生物学和临床后果。
Leukemia. 2017 Apr;31(4):798-807. doi: 10.1038/leu.2017.30. Epub 2017 Jan 23.
5
Efficient DNA binding of NF-κB requires the chaperone-like function of NPM1.NF-κB的有效DNA结合需要NPM1的伴侣样功能。
Nucleic Acids Res. 2017 Apr 20;45(7):3707-3723. doi: 10.1093/nar/gkw1285.
6
Nucleophosmin-anaplastic lymphoma kinase: the ultimate oncogene and therapeutic target.核仁磷酸蛋白-间变性淋巴瘤激酶:终极致癌基因和治疗靶点。
Blood. 2017 Feb 16;129(7):823-831. doi: 10.1182/blood-2016-05-717793. Epub 2016 Nov 22.
7
Nucleophosmin: from structure and function to disease development.核磷蛋白:从结构与功能到疾病发展
BMC Mol Biol. 2016 Aug 24;17(1):19. doi: 10.1186/s12867-016-0073-9.
8
Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.间变性大细胞淋巴瘤起源于胸腺细胞,胸腺细胞迁出胸腺需要短暂表达T细胞受体。
Nat Commun. 2016 Jan 12;7:10087. doi: 10.1038/ncomms10087.
9
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency.NPM-ALK致癌信号的过度激活会促进细胞凋亡和药物依赖性。
Oncogene. 2016 Jul 21;35(29):3854-3865. doi: 10.1038/onc.2015.456. Epub 2015 Dec 14.
10
FOXM1 is a therapeutic target for high-risk multiple myeloma.叉头框蛋白M1是高危多发性骨髓瘤的一个治疗靶点。
Leukemia. 2016 Apr;30(4):873-82. doi: 10.1038/leu.2015.334. Epub 2015 Dec 9.